Seminars in Arthritis and Rheumatism
Volume 39, Issue 4 , Pages 285-293 , February 2010

Survival, Causes of Death, and Risk Factors Associated With Mortality in Spanish Systemic Sclerosis Patients: Results From a Single University Hospital

  • Beatriz E. Joven, MD

      Affiliations

    • Hospital Universitario 12 de Octubre, Servicio de Reumatologia, Madrid, Spain
    • ,
  • Raquel Almodovar, MD

      Affiliations

    • Fundación Hospital Alcorcón, Madrid, Spain
    • ,
  • Loreto Carmona, MD

      Affiliations

    • Unidad de Investigación, Fundación Española de Reumatología, Madrid, Spain
    • ,
  • Patricia E. Carreira, MD

      Affiliations

    • Hospital Universitario 12 de Octubre, Servicio de Reumatologia, Madrid, Spain
    • Corresponding Author InformationAddress reprint requests to Patricia Esmeralda Carreira, MD, Hospital 12 de Octubre, Servicio de Reumatologia, Avda de Cordoba s/n, 28041 Madrid, Madrid, Spain

References 

  1. Barnett AJ, Miller MH, Littlejohn G. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol. 1988;15:276–283
  2. Altman RD, Medsger T, Bloch DA, Michael BA. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum. 1991;34:403–413
  3. Silman A. Mortality from scleroderma in England and Wales. Ann Rheum Dis. 1991;50:95–96
  4. Abu-Shakra M, Lee P. Mortality in systemic sclerosis: a comparison with the general population. J Rheumatol. 1995;22:2100–2102
  5. Nishioka K, Katayama I, Kondo H, Shinkai H, Ueki H, Tamaki K, et al. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis. J Dermatol. 1996;23:677–682
  6. Czirják L, Pákozdi A, Kumánovics G, Varjú C, Szekanecz Z, Nagy Z, et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis. 2008;67:59–63
  7. Simeón CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, et al. Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology. 2003;42:71–75
  8. Jacobsen S, Halberg P, Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol. 1998;37:750–755
  9. Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis. 1998;57:682–686
  10. Bryan C, Knight C, Black CM, Silman AJ. Prediction of five-year survival following presentation with scleroderma. Arthritis Rheum. 1999;42:2660–2665
  11. Ferri C, Valentini G, Cozzi F, Sebatiani M, Michelassi C, La Montagna G, et al. Systemic Sclerosis Study Group of Italian Society of Rheumatology (SIR-GSSSc) Systemic sclerosis demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine. 2002;81:139–153
  12. Scusell-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, et al. Predicting mortality in systemic sclerosis analysis of a cohort of 309 french Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine. 2002;81:154–167
  13. Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and diseases characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48:2246–2255
  14. Alamamos Y, Tsifetaki N, Voulgari PV, Siozos C, Tsamandouraki K, Alexiou GA, et al. Epidemiology of systemic sclerosis in Northwest Greece 1981 to 2002. Semin Arthritis Rheum. 2005;34:714–720
  15. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med. 2005;118:2–10
  16. Mayes MD. Scleroderma epidemiology. Rheum Dis North Am. 2003;29:239–254
  17. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581–590
  18. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28:1573–1576
  19. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202–205
  20. Brennan P, Silman A, Black C, Bernstein R, Coppock J, Maddison P, et al. The UK Study Group Reliability of skin involvement measures in scleroderma. Br J Rheumatol. 1992;31:457–460
  21. Instituto Nacional de Estadística. Demografía y población. Movimiento natural de la población. At: http://www.ine.es/inebase/cgi/.
  22. Silman A. Demographics and survival. J Rheumatol. 1997;24:58–62
  23. Simeón CP, Armadans L, Fonollosa V, Vilardell M, Candell J, Tolosa C, et al. Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis. Ann Rheum Dis. 1997;56:723–728
  24. Silman A. Scleroderma and survival. Ann Rheum Dis. 1991;50:267–269
  25. Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum. 1986;29:515–524
  26. Coral-Alvarado P, Rojas-Villarraga A, Latorre MC, Mantilla RD, Restrepo JF, Pardo AL, et al. Risk factors associated with pulmonary arterial hypertension in Colombian patients with systemic sclerosis: review of the literature. J Rheumatol. 2008;35:244–250
  27. Walker UA, Tyndall A, Czirják L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Sclerodema Trials and Research group database. Ann Rheum Dis. 2007;66:754–763
  28. Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology. 2008;47:1185–1192
  29. Trad S, Amoura Z, Beigelman C, Haroche J, Costedoat N, Boutin Le TH, et al. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum. 2006;54:184–191
  30. Veale DJ, Collidge TA, Belch JJF. Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis. 1995;54:853–855
  31. Stafford L, Englert H, Gover J, Bertouch J. Distribution of macrovascular disease in scleroderma. Ann Rheum Dis. 1998;57:476–479
  32. Ho M, Veale D, Eastmond C, Nuki G, Belch J East of Scotland Systemic Sclerosis Study Group. Macrovascular diseases and systemic sclerosis. Ann Rheum Dis. 2000;59:39–43
  33. Taylor MH, McFadden JA, Bolster MB, Silver RM. Ulnar artery involvement in systemic sclerosis (scleroderma). J Rheumatol. 2002;29:102–106
  34. Khurma V, Meyer C, Park GS, McMahon M, Lin J, Singh RR, et al. A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum. 2008;59:591–597
  35. Kyndt X, Hebbar M, Queyrel V, Hachulla E, Hatron PY, Devulder B. Systemic sclerosis and cancer (Search for predictive factors of cancer in 123 patients with scleroderma). Rev Med Interrne. 1997;18:528–532
  36. Chatterjee S, Dombi GW, Severson RK, Mayes MD. Risk of cancer in scleroderma: a population-based cohort study. Arthritis Rheum. 2005;52:2415–2424
  37. Ruiz-Ramos M, Expósito-Hernández J. Tendencia de la mortalidad por cáncer en Andalucía entre 1975-2003. Med Clin. 2007;128:448–452
  38. Pollán M, Ramis R, Aragonés N, Pérez-Gómez B, Gómez D, Lope V, et al. Municipal distribution of breast cancer mortality among women in Spain. BMC Cancer. 2007;7:78
  39. Ferlay J, Bray F, Sankila R, Parkin DM. EUCAN: Cancer Incidence, Mortality and Prevalence in the European Union 1998, version 5.0. IARC CancerBase No. 4. Lyon: IARC Press; 1999;
  40. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN: Cancer Incidence, Mortality and Prevalence in Worldwide, version 2.0. IARC CancerBase No. 5. Lyon: IARC Press; 2004;

PII: S0049-0172(09)00086-9

doi: 10.1016/j.semarthrit.2009.06.002

Seminars in Arthritis and Rheumatism
Volume 39, Issue 4 , Pages 285-293 , February 2010

Article Tools

* Image Usage & Resolution